Sex, Apolipoprotein E ε4 Status, and Hippocampal Volume in Mild Cognitive Impairment
Archives of NeurologyPublished 1 June 2005
Adam Fleisher
Citations256
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The APOE*E4 genotype status appears to have a greater deleterious effect on gross hippocampal pathology and memory performance in women than in men.
Abstract
The APOE*E4 genotype status appears to have a greater deleterious effect on gross hippocampal pathology and memory performance in women than in men.
Keywords
MedicineNeuroscience
JAMAEffects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease
4,516 Citations1997Lindsay A. Farrer
The APOE∈4 allele represents a major risk factor for AD in all ethnic groups studied, across all ages between 40 and 90 years, and in both men and women.
NeurologyPrediction of AD with MRI-based hippocampal volume in mild cognitive impairment
1,405 Citations1999Clifford R. Jack, Ronald Petersen +8 more
In older patients with MCI, hippocampal atrophy determined by premorbid MRI-based volume measurements is predictive of subsequent conversion to AD.
New England Journal of MedicinePatterns of Brain Activation in People at Risk for Alzheimer's Disease
1,319 Citations2000Susan Y. Bookheimer, Magdalena H. Strojwas +5 more
Patterns of brain activation during tasks requiring memory differ depending on the genetic risk of Alzheimer's disease and may predict a subsequent decline in memory.
NeurologyMedial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease
1,131 Citations1997Clifford R. Jack, Ronald C. Petersen +7 more
Age- and gender-adjusted, normalized MRI-based hippocampal volumetric measurements provide a sensitive marker of the MTL neuroanatomic degeneration in AD early in the disease process.
The LancetApolipoprotein E polymorphism and Alzheimer's disease
1,109 Citations1993J Poirier, J Poirier +11 more
There was a significant association between epsilon 4 and sporadic AD, and apoE may be an important susceptibility factor in the aetiopathology of sporadic AD.
Archives of NeurologyMild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials
961 Citations2004Michael Grundman
Patients with MCI had a predominant memory impairment with relative sparing of other cognitive domains and were intermediate between clinically normal individuals and patients with AD on cognitive and functional ratings.
NeurologyRates of hippocampal atrophy correlate with change in clinical status in aging and AD
945 Citations2000Clifford R. Jack, Ronald C. Petersen +7 more
Rates of hippocampal atrophy match both baseline cognitive status and the change in cognitive status over time in elderly persons who lie along the cognitive continuum from normal to MCI to AD.
ScienceDifferential Effects of Apolipoproteins E3 and E4 on Neuronal Growth in Vitro
802 Citations1994Britto P. Nathan, Stefano Bellosta +4 more
The data suggest that receptor-mediated binding or internalization of apoE-enriched beta-VLDL leads to isoform-specific differences in interactions with cellular proteins that affect neurite outgrowth.
Alzheimer Disease & Associated DisordersDevelopment of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs
703 Citations1997Richard C. Mohs, David S. Knopman +9 more
The major outcome of this investigation was the identification of some potential addtions to the present ADAS that extend both the cognitive domains and the range of symptom severity covered.
Annals of NeurologyUpregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment
691 Citations2002Steven T. DeKosky, Miloš D. Ikonomović +7 more
Cognitive deficits in MCI and early AD are not associated with the loss of ChAT and occur despite regionally specific upregulation, suggesting that the earliest cognitive deficits in AD involve brain changes other than simply cholinergic system loss.
Trends in NeurosciencesTau protein pathology in neurodegenerative diseases
686 Citations1998Maria Grazia Spillantini, Michel Goedert
Experimental studies have provided a system for the assembly of full-length tau into Alzheimer-like filaments, providing an assay for the testing of compounds that inhabit the formation of tau filaments.
Proceedings of the National Academy of SciencesApolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.
600 Citations1995Judes Poirier, Maire-Claude Delisle +8 more
The concept that apoE4 plays a crucial role in the cholinergic dysfunction associated with AD and may be a prognostic indicator of poor response to therapy with acetylcholinesterase inhibitors in AD patients is strongly supported.
JAMAApolipoprotein E Type 4 Allele and Cerebral Glucose Metabolism in Relatives at Risk for Familial Alzheimer Disease
587 Citations1995Gary W. Small
The inheritance of APOE epsilon 4 is associated with reduced cerebral parietal metabolism and increased asymmetry in non-demented relatives at risk for probable AD, and glucose metabolic measures provide a means to monitor experimental treatment responses during the early phases of the disorder.
NeurologyMRI measures of entorhinal cortex vs hippocampus in preclinical AD
577 Citations2002Ronald Killiany, Bradley T. Hyman +7 more
Findings are consistent with neuropathologic data showing substantial involvement of the entorhinal cortex in the preclinical phase of AD and suggest that, as the disease spreads, atrophic change develops within the hippocampus, which is measurable on MRI.
Nature MedicineEstrogen reduces neuronal generation of Alzheimer β-amyloid peptides
555 Citations1998Huaxi Xu, Gunnar K. Gouras +17 more
Evidence is presented that physiological levels of 17beta-estradiol reduce the generation of Abeta by neuroblastoma cells and by primary cultures of rat, mouse and human embryonic cerebrocortical neurons that suggest a mechanism by which estrogen replacement therapy can delay or prevent AD.
PubMedDevelopment of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.
493 Citations1997Richard C. Mohs, David S. Knopman +9 more
Proceedings of the National Academy of SciencesDeclining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease
474 Citations2001Eric M. Reiman, Richard J. Caselli +4 more
This study provides a paradigm for testing the potential of treatments to prevent the disorder without having to study thousands of research subjects or wait many years to determine whether or when treated individuals develop symptoms.
NeurologyMemory and MRI-based hippocampal volumes in aging and AD
423 Citations2000Ronald C. Petersen, Clifford R. Jack +8 more
NeurologyFree testosterone and risk for Alzheimer disease in older men
386 Citations2004Scott D. Moffat, Alan B. Zonderman +5 more
Calculated free testosterone concentrations were lower in men who developed Alzheimer disease, and this difference occurred before diagnosis, and future research may determine whether higher endogenous free testosterone levels offer protection against a diagnosis of Alzheimer disease in older men.
NeurologyEstrogen use, APOE, and cognitive decline
361 Citations2000Kristine Yaffe, Mary N. Haan +3 more
Estrogen use was associated with less cognitive decline among ε4-negative women but not ε 4-positive women, and potential mechanisms, including carotid atherosclerosis, by which ε3 may interact with estrogen and cognition warrant further investigation.
Proceedings of the National Academy of SciencesTestosterone reduces neuronal secretion of Alzheimer's β-amyloid peptides
303 Citations2000Gunnar K. Gouras, Huaxi Xu +5 more
Treatment with testosterone increases the secretion of the nonamyloidogenic APP fragment, sbetaAPPalpha, and decreases the secretionof Abeta peptides from N2a cells and rat primary cerebrocortical neurons, raising the possibility that testosterone supplementation in elderly men may be protective in the treatment of AD.
PubMed[Apolipoprotein E polymorphism and Alzheimer disease].
300 Citations1996van der Weide J, Steijns Ls +3 more
The epsilon 4 allele of the apoE gene may be considered as a biological risk factor for the development of Alzheimer's disease and genotyping seems to be a supplementary tool for risk assessment in geriatric patients with cognitive impairment.
Journal of NeuroscienceAge and Gender Predict Volume Decline in the Anterior and Posterior Hippocampus in Early Adulthood
297 Citations2001Jens C. Pruessner, D. Louis Collins +2 more
Results suggest a larger shrinkage for men of brain gray matter, with controversial observations being made for the HC, and underscores the need to include sociodemographic variables in functional and anatomical MRI designs.
Journal of Biological ChemistryThe Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization
275 Citations1995Britto P. Nathan, Kung-Ching Chang +5 more
The depolymerization of microtubules and the inhibition of neurite outgrowth associated with apoE4 suggest a mechanism whereby apo E4 may prevent normal neuronal remodeling from occurring later in life, when this neurodegenerative disorder develops.
Annals of NeurologyParahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease
252 Citations2002Thomas W. Mitchell, Elliott J. Mufson +9 more
Data indicate that phosphorylated tau pathology in the ventromedial temporal lobe develop prior to the onset of clinical dementia and their presence is associated with cognitive impairment, particularly impairment of episodic memory.
NeurologyEpisodic memory changes are associated with the APOE- epsilon 4 allele in nondemented older adults
240 Citations1995Mark W. Bondi, David P. Salmon +6 more
Results suggest that episodic memory changes in older adults are associated with APOE- epsilon 4 allele; sensitive cognitive markers such as those of the CVLT may precede the subsequent development of DAT.
Journal of NeuroscienceIncreased Synaptic Sprouting in Response to Estrogen via an Apolipoprotein E-Dependent Mechanism: Implications for Alzheimer’s Disease
240 Citations1998David J. Stone, Irina Rozovsky +3 more
A mechanism for the protective effects of estrogens on AD is suggested and a link between two important risk factors in the etiology of AD, the apoE ε4 genotype and an estrogen-deficient state is provided.
Neuroscience LettersEstradiol protects against β-amyloid (25–35)-induced toxicity in SK-N-SH human neuroblastoma cells
233 Citations1996Pattie S. Green, Kelly E. Gridley +1 more
RadiologyMR imaging-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies.
199 Citations1990Clifford R. Jack, Michael D. Bentley +2 more
The results indicate that MR-based volume measurements of these brain structures can be made with high precision and reproducibility.
Alzheimer Disease & Associated DisordersEvidence for an Interaction between Apolipoprotein E Genotype, Gender, and Alzheimer Disease
190 Citations1999P. Bretsky, J. Galen Buckwalter +6 more
The analysis suggests that the presence of one or more APOE-epsilon4 allele confers a substantially greater risk of AD to women than to men, which may account for reports of increased risk ofAD faced by women.
NeurologyHippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes
173 Citations2002Tom den Heijer, Matthijs Oudkerk +4 more
The authors assessed the impact of APOE genotype on hippocampal, amygdalar, and global brain atrophy as putative markers of preclinical AD in a nondemented population.
NeurologyLongitudinal change in hippocampal volume as a function of apolipoprotein E genotype
169 Citations2000Scott D. Moffat, Christine A. Szekely +3 more
Results indicate that individuals positive for the APOE ε4 allele may show a greater rate of hippocampal atrophy than theirε4− counterparts, even in the absence of a diagnosis of AD.
NeurologyApolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer’s disease
142 Citations2001Mamoru Hashimoto, M. Yasuda +5 more
Different patterns of regional brain atrophy were found among patients of different APOE genotypes, suggesting that the effect of APOE ε4 allele on the brains of AD patients may have regional specificity.
Journal of Neurology Neurosurgery & PsychiatryMajor decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon 4 allele
132 Citations1998Kirsi Juottonen, Maarit Lehtovirta +3 more
Volumetric MRI measurements disclose that ApoE ε4 is associated with the degree of atrophy in the entorhinal cortex in early Alzheimer's disease, this effect being especially prominent in female patients with Alzheimer’s disease.
JAMAApolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease
120 Citations1995Gary W. Small
NeurologyGender and age modify the association between APOE and AD-related neuropathology
108 Citations2001Estifanos Ghebremedhin, Christian Schultz +5 more
The results confirm the association between the ε4 allele and both types of AD-related lesions and show that this association is differentially modified by age and gender.
Journal of Molecular NeuroscienceSteroid Hormones and Cognitive Functioning in Aging Men: A Mini-Review
74 Citations2003Barbara B. Sherwin
Findings from the extant literature provide some support for the notion that estrogen is important for aspects of memory in aging men, just as it is in women, whereas T helps to maintain visuospatial abilities.
NeurologyPlasma testosterone levels in Alzheimer and Parkinson diseases
73 Citations2004Michael S. Okun, Mahlon R. DeLong +3 more
Ass associations between low testosterone levels and frontal lobe dysfunction in normal aged men, together with these results, suggest that the hormonal deficiency may act as a “second hit” to impair cognitive function in neurodegenerative disease.
Journal of Molecular NeuroscienceHippocampal Volume Is Associated with Memory but not Nonmemory Cognitive Performance in Patients with Mild Cognitive Impairment
70 Citations2003Michael Grundman, Clifford R. Jack +14 more
It is concluded that the relationship between hippocampal volume and risk of AD is likely tied to reduced memory performance and not associated with impairment in nonmemory cognitive domains.
Annals of the New York Academy of SciencesPredictive Value of APOE Genotyping in Incipient Alzheimer's Diseasesa
58 Citations1996Ronald C. Petersen, Stephen C. Waring +3 more
It is indicated that APOE is an important risk factor for AD, and in patients with a mild cognitive impairment, APOE may be useful in predicting who is likely to progress to dementia.
Acta Neurologica ScandinavicaThe neurochemistry of Alzheimer's disease
49 Citations1996Kaj Blennow, Richard F. Cowburn
The evidence for the involvement of β‐amyloid and tau proteins in Alzheimer's disease pathogenesis based on postmortem brain and CSF studies is provided.